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Abstract
Fluctuations in tumor blood flow are common and attributed to factors such as vasomotion or local vascular structure, yet,
because vessel structure and physiology are host-derived, animal strain of tumor propagation may further determine blood
flow characteristics. In the present report, baseline and stress-altered tumor hemodynamics as a function of murine strain
were studied using radiation-induced fibrosacomas (RIF) grown in C3H or nude mice. Fluctuations in tumor blood flow
during one hour of baseline monitoring or during vascular stress induced by photodynamic therapy (PDT) were measured
by diffuse correlation spectroscopy. Baseline monitoring revealed fluctuating tumor blood flow highly correlated with heart
rate and with similar median periods (i.e., ,9 and 14 min in C3H and nudes, respectively). However, tumor blood flow in
C3H animals was more sensitive to physiologic or stress-induced perturbations. Specifically, PDT-induced vascular insults
produced greater decreases in blood flow in the tumors of C3H versus nude mice; similarly, during baseline monitoring,
fluctuations in blood flow were more regular and more prevalent within the tumors of C3H mice versus nude mice; finally,
the vasoconstrictor L-NNA reduced tumor blood flow in C3H mice but did not affect tumor blood flow in nudes. Underlying
differences in vascular structure, such as smaller tumor blood vessels in C3H versus nude animals, may contribute to strain-
dependent variation in vascular function. These data thus identify clear effects of mouse strain on tumor hemodynamics
with consequences to PDT and potentially other vascular-mediated therapies.
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Introduction
Blood flow in tumors is a highly dynamic process that is
commonly observed to fluctuate over time [1]. Fluctuations over
timescales on the order of minutes or tens of minutes have been
identified in the tumors of many animal models, as well as in
human disease [1,2,3,4]. These fluctuations, documented both at
the individual and network blood vessel level [5], have been
attributed to causes such as vascular intussusception from rapid
vessel remodeling, locally-determined hemodynamics, and co-
ordinated vasomotion under upstream control [3]. Importantly,
temporal variations in tumor blood flow can affect therapy
response, such as in the delivery of oxygen or drugs to the tumor
[6]. Furthermore, tumor blood flow can reflect the extent of
structural adaption by its vasculature [7], and therefore can
provide potentially useful information about the developmental
status of the tumor blood vessels and their capability for
hemodynamic response.
Although infrequently considered in studies of tumor blood
flow, the animal strain of tumor propagation is a possible variable
of hemodynamic consequence. Some appreciation of the effect of
animal strain on tumor blood flow and oxygenation can be gained
from experiments that have examined these parameters as
a function of tumor model. In a study by Guichard et al. [8],
for example, SCCVII mouse tumors grown in C3H hosts
experienced large decreases in blood flow after hydralazine
administration (e.g. larger than analogous decreases in human
tumors grown in nude mice), but the data revealed that the
hydralazine effect in SCCVII tumors was smaller when implanted
in nude versus C3H mice. In a related vein, Yasui et al. [9]
reported that differences in pericyte density contributed to
disparities in vascular function and oxygenation between tumor
models grown in C3H versus nude murine hosts. Outside of the
oncology field, a role for mouse strain in cardiovascular function
and stress response is well documented [10,11].
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that vascular response during photodynamic therapy (PDT) of
tumors differed between mouse strains. In PDT a photosensitizer
and visible wavelengths of light are employed to cause local tissue
damage, which for many protocols includes damage to blood
vessels [12,13]. This effect is evidenced by the substantial change
and variability in tumor blood flow during the illumination period
of PDT [13,14,15,16,17]. During PDT with the photosensitizer
Photofrin, for example, tumor blood flow decreases during
illumination at a rate that correlates with long-term tumor
response [14]. Others have shown the luminal diameter of tumor
blood vessels to progressively decrease during PDT, thus
demonstrating that vasoconstriction contributes to decreases in
blood flow during Photofrin-mediated treatment [18].
The effect of pre-existing tumor blood flow on vasoresponse to
PDT has been considered by He et al. [19]. They showed that
vessels with slower blood flow were more rapidly shut down after
PDT. It has also been observed that tumor areas with low pre-
existing pO2 experience larger decreases in tumor oxygenation
after PDT [20]. This observation is consistent with the results of
He et al., because it is likely that low pO2 areas suffered from low
blood flow (at least temporarily). Indeed, correlations between
oscillations in local tumor blood flow and fluctuations in pO2 have
been reported [1,5].
Our initial observation of strain-dependent decreases in tumor
blood flow during PDT led us to the hypothesis that baseline
tumor hemodynamic function differed between strains. Herein, we
evaluate differences in the structure and function of tumor blood
vessels between mouse strains through studies of the same tumor
model, the radiation-induced fibrosarcoma (RIF), grown in its
syngeneic host, C3H mice, or, alternatively, in nude mice. The
results identify little-explored characteristics of baseline blood flow
in tumors, including correlations between low frequency fluctua-
tions (,9–14 min periods) in tumor blood flow and animal heart
rate. Moreover, when compared to tumor blood flow in nudes,
tumor blood flow in C3H animals was more sensitive to
physiologic or stress-induced perturbations. From these data we
conclude that the underlying structure and hemodynamics of
tumor blood vessels may inform upon the nature of their response
to a subsequent vascular challenge.
Materials and Methods
Ethics Statement
All animal studies were approved by the University of
Pennsylvania Institutional Animal Use and Care Committee and
animal facilities are accredited by the American Association for the
Accreditation of Laboratory Animal Care.
Animals and tumor model
RIF tumors were propagated by the intradermal injection of
3610
5 cells over the shoulders of 9–11 week old female C3H
(C3H/HeNCr) or nude (NCr-nu/nu) mice (NCI-Frederick,
Frederick, MD). Animals were studied ,7–10 days later when
their tumors were ,6–8 mm in diameter. The fur in C3H mice
was clipped prior to cell inoculation and the treatment area
depilated (Nair) at least 24 hours before monitoring with diffuse
correlation spectroscopy and treatment with PDT.
Experimental protocol
Throughout monitoring and PDT, mice were positioned on
a heating pad set to 38uC (Gaymar Industries, Orchard Park, NY)
and were anesthetized by inhalation of isoflurane in medical-air
delivered through a nose-cone (VetEquip anesthesia machine,
Pleasanton, CA). Concurrent with optical data acquisition,
systemic physiological signals of heart rate (HR) and breath rate
(BR) were recorded with a vitals monitor (MouseOx, Starr Life
Sciences Corp., Allison Park, PA), through a sensor placed on the
hind leg of the animal (acquisition rate of 1 Hz). In selected
experiments, tumor and animal core temperatures were also
measured via thermocouple (Omegaette HH306 DataLogger
Thermometer and Thermoworks Microtherma thermometer with
Braintree Type T Thermocouple Copper-Constantan rectal
probe). Animals underwent one hour of baseline monitoring by
diffuse correlation spectroscopy (see below) prior to PDT or L-
NNA (N
G-nitro-L-Arginine; Sigma, St. Louis, MO) injection,
followed by continuous monitoring throughout PDT or 60 min-
utes after L-NNA injection. L-NNA was administered via the
orbital plexus at a dose of 20 mg/kg (dissolved in saline). PDT was
performed as described below. Photofrin concentrations in tumors
were assayed as previously described [21].
Photodynamic therapy
For photodynamic therapy (PDT) animals received an i.v. tail
vein injection of Photofrin (available from Pinnacle Biologics,
Bannockburn, IL) at 5 mg/kg and 24 h later microlens-tipped
fibers (Pioneer, Bloomfield, CT ) were used to deliver 63263n m
light from a Ceralas diode laser (Biolitec AG, Jena, Germany) over
a 1.1 cm diameter field centered on the tumor. Laser output was
measured with a LabMaster power meter (Coherent, Auburn, CA)
and adjusted to deliver an irradiance of 75 mW/cm
2 at the tumor
surface. A total fluence of 135 J/cm
2 was delivered to the tumor.
Diffuse correlation spectroscopy
Tumor blood flow was continuously monitored with a non-
invasive optical technique known as Diffuse Correlation Spectros-
copy (DCS) [14,22,23]. Diffuse optical techniques employ photons
in the near-infrared range that diffuse through tissue and can be
detected millimeters to centimeters away from the source. DCS
quantifies the temporal fluctuations of detected light. These
fluctuations are sensitive to the motions of scatterers in tissue such
as red blood cells. Therefore, the DCS signal provides a direct
measure of blood flow, and can be used to derive a blood flow
index (BFI) parameter. This technique is used herein to derive
microvascular relative blood flow (rBF), i.e. blood flow changes
relative to a baseline period (rBF(t)=BFI(t)/BFIbaseline). The
baseline was taken as mean BFI over the one hour of monitoring
at each source-detector combination. Tumor rBF variations due to
PDT were calculated by normalizing to the BFI obtained two
minutes before beginning of illumination. Similarly, tumor rBF
changes due to L-NNA were calculated by normalizing to the BFI
obtained during the last two minutes of the baseline period.
DCS measurements were performed with a home-built in-
strument containing one continuous-wave, long coherence length,
785 nm laser (CrystaLaser Inc., Reno, NV), and four single-
photon counting avalanche photodiodes (PerkinElmer, Canada).
The laser source was coupled to an optical switch with nine
outputs to provide information from up to 36 source-detector
combinations designed to cover the whole tumor area. Both source
and detector optical fibers were arranged in a two-dimensional
pattern inside a non-contact probe composed of a camera and
neutral density optical polarizing filter. The lens of the camera was
positioned about 15 cm above the tumor. The separations
between a source and a detector position on the surface of the
tumor ranged from 0.97 to 4.37 mm. The detectors fed a 4-
channel autocorrelator board (Correlator.com, Bridgewater, NJ)
that computed the temporal intensity autocorrelation function.
The whole cycle took approximately 16 s.
Strain-Dependent Differences in Tumor Blood Flow
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by fitting the temporal intensity autocorrelation functions to a semi-
infinite homogeneous medium diffusion model that approximates
the mean-square displacement of the scatterers in tissue as
a Brownian motion in a semi-infinite homogeneous medium
[23,24]. The mean tumor rBF of each animal was calculated by
averaging tumor rBF over all the source-detector combinations,
and is displayed as a percentage of values obtained during the
baseline period.
Phosphorescence lifetime measurements
Phosphorescence lifetime measurements were employed to
measure tumor oxygenation during the one-hour baseline period.
The measurement generally followed our recently published
protocol [25]. Oxyphor G4 (20 mlo f2 0mM solution) was injected
directly into the tumor interstitial space and phosphorescence was
measured using a fiber-optic phosphorometer [26] modified for
time-domain operation. Phosphorescence was excited by 10 ms-
long LED pulses (lmax=635 nm) and decays were collected over
3 ms period. Typically, 200 decays were averaged for a single
measurement, and the measurements were recorded every 4 s.
The data were analyzed by way of single-exponential fitting and
subsequent conversion of the phosphorescence lifetime to pO2
using appropriate calibrations [25].
Immunohistochemistry
In tumors from C3H and nude animals immunohistochemistry
was used to quantify blood vessels and smooth muscle actin (SMA)
expression. Frozen tumors preserved in Tissue Tek OCT
Compound (Sakura Finetek, Torrance, CA) were sectioned
(14 mm) on a Microm HM 505E Cryostat (Microm International
GmbH, Walldorf, Germany) and fixed in graded solutions of
ethanol (70%, 85% and 100% at 4uC, followed by 100% at room
temperature). Following a previously published procedure for
CD31 staining [27], vascular structure was labeled with a CD31
antibody (1:100 for 1 h; BD Pharmingen, San Diego, CA) and
vessel maturity with an antibody to smooth muscle actin (1:100 for
1 h; GeneTex, Irvine, CA). Respective to these primary anti-
bodies, secondary antibodies of Cy5-conjugated mouse anti-rat
(1:50 for 45 min; Jackson Immunoresearch, West Grove, PA) and
FITC-conjugated donkey anti-rabbit (1:200 for 1 h; Jackson
Immunoresearch) were used. Sections were flooded with Hoechst
33342 (20 mM) to label tissue, and images (106) were collected by
fluorescence microscopy using a Nikon Eclipse 800 microscope
(Melville, NY) with a motorized stage (Ludl electronics;
Hawthorne, NY) and 100-W high pressure mercury arc lamp
and Photometrics Quantix CCD digital camera (Tucson, AZ).
Analysis entailed masking of CD31, SMA and Hoechst-stained
areas; identification of CD31 ‘‘objects’’ based on contiguous
staining; and calculation of ‘‘object’’ size, as well as the percentage
of tumor positive for CD31 or SMA. All steps of this analysis were
performed using routines in the Image toolbox in MATLAB
(MathWorks, Natick, MA) with the exception of masking for SMA
and Hoechst, which utilized Adobe Photoshop (Adobe Systems
Inc., San Jose, CA). Controls included slides stained with
secondary (but no primary) antibody, and demonstrated no
staining.
Data analysis and statistics
Hemodynamic time-series during PDT were averaged over all
the source-detector pairs. rBF response due to PDT was estimated
by the difference between two reference points in the temporal rBF
time-series: the point when rBF initially declined and the point
when it plateaued. These ‘‘change points’’ were found based on
the likelihood ratio method. The L-NNA induced decrease was
reported as the lowest rBF level between 10 and 40 minutes after
L-NNA administration.
For the one-hour monitoring prior to any intervention, trends
were obtained by fitting the raw time-series by a cubic polynomial
to capture the global trend. Fluctuations in tumor rBF were
quantitatively analyzed by calculating the autocorrelation function
(ACF) of the de-trended time-series (i.e. the residuals after
removing the global trend). For each mouse, quantification of
the cyclic patterns was performed by averaging the first 3 time lags
of the ACF (equivalent to approximately a 1-minute window), then
taking the median of this number over all the source-detector
pairs.
In order to investigate the relationship between tumor rBF and
mouse physiology (assessed by HR or BR), we calculated the cross-
correlation between the two raw time-series, discarding the first
5 minutes of the steady-state period to avoid initial instability. The
acquisition time for each of 36 tumor rBF series was matched with
the physiological data, which were then down-sampled to match
the tumor rBF acquisition rate by averaging HR/BR over the
appropriate time interval. The maximum cross-correlation value
across the time series was used to quantify the degree of correlation
between mouse physiology and tumor rBF.
In all the procedures above, tumor rBF for each source-detector
combination was analyzed independently. For each animal, the
median tumor rBF response was calculated by taking the median
over all source-detector combinations. The data for each group of
animals were summarized using either the median and the
interquartile range (IQR), or the mean and the standard deviation
(SD). Wilcoxon signed rank tests were used to assess statistically
significant differences between the tumors of different strains, as
well as within the tumors of each strain at different time points.
Results
PDT-induced reductions in tumor blood flow differ in
magnitude between C3H and nude mice
We have previously demonstrated that tumor blood flow
markedly decreases during the illumination period for Photofrin
PDT [14]. We confirm these results in the present investigation;
a representative trace of rBF in RIF tumors of C3H mice is plotted
in Fig. 1A (upper panel). RIF tumors of nude hosts (lower panel)
also experience decreases in blood flow during PDT. Notably,
however, the decrease in tumor rBF in nude animals is
significantly less than that in C3H mice bearing the same tumor
line; the median (IQR) PDT-induced decrease in blood flow is
291% (297,286%) in C3H compared to 275% (276,254%) in
nudes (p=0.026; Fig. 1B). No differences in Photofrin uptake were
detectable between RIF tumors excised from the two mouse
strains, and thus drug uptake does not account for strain-
dependent vascular response (mean 6 SD of Photofrin uptake is
3.6361.92 and 3.8361.60 ng/mg in C3H and nudes, respective-
ly). These observations led us to hypothesize that underlying
vascular function differed across the tumors of C3H and nude
animals. To test this hypothesis, we studied tumor blood flow in
anesthetized, but otherwise unperturbed animals of each strain.
For analysis, the blood flow patterns were separated into two
components: long term trends and cyclic patterns (i.e. fluctuations
around the trends).
Murine tumors demonstrate cycles in blood flow that
depend on mouse strain
Blood flow in tumors can fluctuate in repetitive cycles of various
frequencies attributable to the effects of vasomotion or local
Strain-Dependent Differences in Tumor Blood Flow
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such cycles were clearly visible in selected animals of both the C3H
and nude strains (Fig. 2A). When considering all of the animals of
a given strain, it became apparent that the consistency of cycling
differed between the strains. C3H mice were characterized by
more well-defined and regularly-cycling tumor blood flow than
nudes. The regularity of the blood flow oscillations is readily
quantified using the autocorrelation function (ACF), which
essentially provides a measure of the correlation between two
sequentially observed blood flow values (traces) from the same
animal as a function of the time lapse (or time lag) between the
observations. If the cyclic pattern in rBF is clear, and if the
oscillation period is well defined, then the ACF will decrease
smoothly as the time lag increases. On the other hand, a lack of
periodicity leads to a quick drop of the ACF after the very first
time lag. Across animals, the median (IQR) ACF value was 0.77
(0.69,0.79) in tumors of C3H mice over 60 minutes of monitoring;
this median ACF is significantly higher (p=0.003) than the
median ACF of 0.49 (0.39,0.71) for tumors in nude animals
(Fig. 2B). The higher ACF in the C3H group reflects a more
pronounced periodic behavior of tumor rBF when compared to
the nude group.
In addition to demonstrating more regularity in blood flow
within their tumors, in comparisons among animals, C3H mice were
more likely to host tumors with cyclic blood flow than their nude
counterparts; thus, cycling tumor blood flow was more prevalent
among C3H than nude animals. This observation is quantifiable
through the distribution of the ACF among the animals of each
strain. While most of the C3H animals presented with ACF.0.6,
the ACF in the nude mice was distributed throughout a range
from 0.1 to 0.9 (Fig. 2C), wherein the lowest values correspond to
animals that essentially showed no periodicity. Overall, 2 of the 17
animals in the nude group (12%) exhibited no visibly clear pattern
in their temporal patterns of flow. Among animals in the nude
group that did demonstrate visible regular oscillations, the median
(IQR) period length was 9.1 (7.8, 10.9) min. In the tumors of C3H
mice, all animals demonstrated a regular oscillation with a median
length of 13.6 (10.9,18.1) min. Thus among animals that
demonstrated periodic blood flow, that period length was similar
between the strains; however, strain-dependent differences were
evident by the fact that all the C3H animals exhibited regular
periodicity while 12% of nudes did not.
Cycles in tumor blood flow associate with animal heart
rate in both strains
Since the present investigation identified synchronized, tumor-
wide blood flow changes (i.e. the volume over which DCS
averaged), we sought a systemic cause for the oscillations. Fig. 3A
shows representative time-courses of rBF, HR and BR for a single
anesthetized C3H mouse over a 1-hour period. The similarity of
the temporal fluctuations in tumor blood flow and the mouse heart
rate is evident. On the other hand, fluctuations in tumor rBF do
not appear to be temporally related to fluctuations in the mouse
breath rate. For this animal, scatter plots depict the close
relationship between HR and tumor rBF, and the absence of
such a relationship between BR and tumor rBF (Fig. 3B). Indeed,
the cross-correlation coefficient between rBF and HR (BR) yielded
0.87 (20.09) for this specific mouse. Across animals, the median
(IQR) correlation coefficient between rBF and HR was 0.51
(0.35,0.67) for C3H and 0.49 (0.39,0.74) for nudes. Both values are
higher than zero (p,0.001), indicating a significant association
between tumor rBF and mouse HR for both strains. In contrast,
tumor rBF and mouse BR showed a very weak correlation with
cross-correlation coefficients of 0.25 (0.14,0.32) and 0.29
(0.13,0.39) in C3H and nudes, respectively.
It is worth noting that the association between tumor blood flow
and animal heart rate was decoupled by the local vascular stress of
PDT. In both strains, PDT-induced change in tumor blood flow
served to override its dependence on animal HR. Representative
examples show both heart rate and breath rate to be poorly
correlated with tumor rBF during PDT (Fig. 3C); across animals,
the median cross-correlation between tumor rBF and mouse HR
was not significantly different from zero in either model, being
0.22 (20.40,0.57) and 0.10 (20.07,0.16) in C3H and nudes,
respectively.
Long-term trends in tumor blood flow demonstrate
increases in C3H mice
To assess overall trends in tumor blood flow over time, rBF in
anesthetized animals was compared between three defined periods
during 1 hour of monitoring: initial rBF (average of the first 0–
2 minutes), short-term rBF (average of 10–15 minutes into
monitoring), and equilibrated rBF (average of 55–60 minutes into
Figure 1. Strain-dependent differences in tumor blood flow
during PDT. (A) Representative rBF time-courses in RIF tumors for
a C3H and a nude mouse during 30 minutes of illumination with PDT
(t=0). The lines A and B represent the change points marking the
beginning of the decrease in rBF and the plateau in rBF level,
respectively, and were used to define the change in rBF (i.e.
DBF=rBFA2rBFB). (B) Box plots of blood flow changes (DBF) during
PDT within animals of each strain (N=7 for each strain); PDT decreased
rBF in both groups (p=0.016 for both C3H and nudes), with the
decrease in C3H larger than that in nudes (p=0.026).
doi:10.1371/journal.pone.0037322.g001
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Fig. 3A, along with a representative example of a global trend line
fit to the data. Table 1 summarizes the median changes in rBF
trends for these time ranges in both strains. Overall, the C3H
group showed a median (IQR) significant increase of 26%
(18,39)% in rBF over the 60-minute period (p=0.0001). However,
this increase was not constant over time, since half of it happened
within the first 15 minutes of monitoring, while the remaining
change occurred over the next 45 min. In contrast, tumor rBF did
not change significantly in the nude group, with a slight median
increase of 9% (211,29)% over 60 minutes.
Accompanying these strain-dependent differences in tumor
blood flow over the 60 min period were strain-dependent
differences in mouse heart rate. However, neither tumor nor
animal core temperature changed in either strain. Over 60 min-
utes, C3H heart rate increased significantly (p=0.0001) from
a median (IQR) of 426 (405,436) beats per minute to 491 (459,515)
beats per minute. In contrast, the change in nude heart rate from
428 (394,454) beats per minute to 442 (350,464) beats per minute
was not significant (p=0.82). Mean (SD) tumor temperature
remained steady in both strains, measured at 27.3 (1.1) uC during
the first two minutes and 28.3 (1.3) uC during the last five minutes
in C3H and at 27.9 (1.2) uC during the first two minutes and 28.8
(0.7) uC during the last five minutes in nudes. Similar non-
significant changes were found in core temperature, with values
changing from 31.2 (1.5) uC to 32.1 (1.1) uC in C3H and from 32.2
(1.5) uC to 32.8 (1.1) uC in nudes. Thus, there was no evidence of
temperature contributing to the differential blood flow responses
between nudes and C3H, but strain-dependent change in heart
rate is aligned with the blood flow change.
Given the increases in C3H tumor blood flow, we speculated
that tumors of C3H animals may be more oxygenated than those
of nude animals. Because PDT is oxygen-dependent, this could
facilitate the stronger PDT-mediated vascular response found in
C3H (see Fig. 1). To study this possibility, phosphorescence
lifetime measurements were used to assess tumor oxygenation in
C3H and nude animals (Fig. 4). Average (SD) tumor oxygen
tension in the first two minutes of anesthesia was 18 (13) Torr and
21 (16) Torr in nudes and C3H, respectively, which changed to 33
(10) Torr in nudes and 20 (12) Torr in C3H at the conclusion of
60 min. There is substantial overlap among these values, both
between the animal strains at a given time and between the time
points in a given strain. These data show that RIF tumors in C3H
mice were not better oxygenated than those in nude mice on an
absolute basis over the 1-hour period (p=0.13), nor did their
tumor oxygen tension increase in a statistically significant fashion
Figure 2. Cyclic tumor blood flow at baseline depends on mouse strain. (A) Representative rBF time-courses in RIF tumors for a C3H and
a nude mouse during one hour of unperturbed monitoring. (B) Mean autocorrelation function (ACF) across signal-detector pairs of the first three lags
(equivalent to 1 minute) for each strain; p=0.003 for the difference between the strains. (C) Histogram of the distribution of the mean ACF among
the mice of each strain. (N=17/15 for nudes/C3H).
doi:10.1371/journal.pone.0037322.g002
Strain-Dependent Differences in Tumor Blood Flow
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animals, respectively). Trends of increasing blood flow in the C3H
animals did not lead to differentially better oxygenation of the
tumors in these animals compared to those of the nudes.
Response to vasoconstrictor L-NNA also differs between
strains
In order to explore the generality of strain effects on vascular
dynamics, we next evaluated rBF response to vasoconstriction
induced by nitric oxide synthase inhibition with L-NNA. The
typical time-course of LNNA-induced blood flow reduction is
shown in representative traces from tumors in a C3H and a nude
mouse (Fig. 5A), and from these the maximum L-NNA induced
decrease was measured in a 30 min window between 10 to 40 min
after drug injection. This analysis revealed tumor rBF to
significantly decrease after L-NNA administration in the C3H
group, with a median (IQR) decrease of 222% (233,217%)
(p=0.016). On the other hand, nude animals experienced a wider
range of responses to L-NNA, leading to a non-significant
(p=0.16) change of 212% (233,21%) in tumor rBF(Fig. 5B).
Strain-dependent differences in tumor vascular structure
Taken collectively, the above data find the hemodynamics of
RIF tumors in C3H mice to be more tightly regulated, as shown
by its regular cyclic patterning and reactivity to both local (PDT)
and systemic (L-NNA) vascular stress. These results could be
reflective of an underlying difference in the vascular makeup of the
tumors, leading us to compare the vascular composition of RIF
tumors grown in C3H versus nude animals. Vascular areas were
similar between the tumor models. On average (SD), RIF tumors
in C3H mice had a vascular area of 7.5 (3.7)%, compared to
a vascular area of 8.7 (3.5)% in the nude animals. In contrast,
though, the size of the tumor blood vessels differed significantly
between strains. In C3H mice median vessel size was an average
(SD) of 53 (19) mm
2. In nudes the tumor blood vessels were
significantly larger (p=0.02) at 130 (33) mm
2 (Fig. 6).
Discussion
Vascular damage is an important mechanism of PDT action
with many photosensitizers and photosensitizing conditions. The
Figure 3. Tumor blood flow is closely associated with animal heart rate. (A) Representative time-courses of tumor rBF, heart rate (HR) and
breath rate (BR) for a C3H animal during one hour of unperturbed monitoring. The shadowed areas represent the time periods for trend analysis
presented in Table 1, while the blue line shows the fitted global trend line. (B) For the animal in ‘‘A’’, scatter plots (at time lag 0) depict the association
between rBF and HR (left) or rBF and BR (right) during the one hour of baseline monitoring or (C) during PDT. The r values in the scatter plots
represent the maximum cross-correlation value between the two variables.
doi:10.1371/journal.pone.0037322.g003
Table 1. Strain-dependent changes in rBF trends at three different time periods during one hour of unperturbed monitoring.
Strain Time Ranges (min) Median (IQR) changes (%) Significant change from zero (p-value)
C3H 15 vs. 2 13 (10, 25) 0.0001
60 vs. 2 26 (18,39) 0.0001
60 vs. 15 11 (4,19) 0.003
Nude 15 vs. 2 1 (26,9) 0.49
60 vs. 2 9 (211,29) 0.28
60 vs. 15 6 (28,12) 0.21
Baseline level of rBF increases in C3H animals, but is stable in nudes.
doi:10.1371/journal.pone.0037322.t001
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photosensitizer type, photosensitizer dosing, drug-light interval,
fluence, and fluence rate [28,29,30,31]. However, the effect of
animal strain on PDT-induced vasoresponse has barely been
considered. This led us to investigate how tumor hemodynamics
during PDT differed between RIF tumors as a function of their
propagation in C3H versus nude mice. Tumors of C3H mice
developed more severe ischemia during PDT, and this finding
could not be attributed to differences in either photosensitizer
uptake or pre-existing oxygen tensions between tumors of the two
strains. In contrast, tumor vessels of C3H mice were smaller than
those in nudes and demonstrated more tightly controlled
hemodynamics, evidenced by the presence and regularity of cyclic
blood flow patterns; cyclic patterns were absent or not as well
defined in the larger tumor blood vessels of the nude mice. Our
data show that these strain-dependent differences in tumor
hemodynamics have implications in studies of PDT. These
differences may also play a role in response to systemic but less
severe vascular insults, such as the vasoconstrictor L-NNA, which
led to significant decreases in tumor blood flow in C3H but not
nude mice.
A role for mouse strain in the response of tumor blood flow to
vasoactive drugs has previously been unclear. A handful of papers
have considered this possibility with the conclusion that animal
strain did not play a role because differentials in blood flow
response between strains were small compared to differences
between tumor models [8,32]. Nevertheless, the data showed
drug-induced changes in blood flow to be slightly bigger for the
same tumor model grown in C3H mice versus nude or SCID
animals. Laser Doppler was used to measure tumor blood flow in
these studies resulting in a sampled area that was small (,1m m
3)
compared to the tumor-wide average provided by DCS in the
present study. Given the known intra-tumor heterogeneity in
tumor vascularization and its reactivity these differences in
sampling size could readily explain the more clear-cut results of
the present study.
The immune system is a factor that should be considered when
comparing vascular damage between nude and C3H animals.
Propagation of the same tumor model in two different murine
strains necessitated that one of theses strains be immunodeficient.
Previous reports have shown that the efficiency of PDT is
compromised in immunodeficient hosts [33]. The fact that C3H
mice have an intact immune system, while nude mice are athymic
and immune deficient, may account for some of the strain-
dependent differences due to PDT. However, it is unlikely that the
differences we found were a result of differences in T-cell response
to PDT because our studies were limited to changes in blood flow
during the course of PDT (30 minute treatment), which is likely
earlier than the consequences of T-cell deficiency on PDT
outcomes would be realized in the nude animals.
On the other hand, immunological-dependent differences in
strain responses could be mediated through its effect on tumor
development. Solesvik et al. [34] have documented differences in
the vascular composition of multiple tumors lines when propagat-
ed in nude versus C3H hosts. Specifically, in the tumors of C3H
mice, small diameter (,10 mm) blood vessels were significantly
longer, in fact sometimes twice as long, as blood vessels of similar
diameter in the tumors of nudes. Given the tortuous nature of
Figure 4. Tumor oxygenation is not significantly different
between the two strains. Tumor oxygenation (mean 6 SD) in
animals of each strain for measurements made at the beginning and
the end of a one-hour period. Oxygen concentrations measured by
phosphorescence lifetime monitoring. (N=6 for each strain.)
doi:10.1371/journal.pone.0037322.g004
Figure 5. L-NNA decreases tumor blood flow in C3H animals.
(A) Representative rBF time-courses in RIF tumors for a C3H and a nude
mouse after L-NNA administration (represented by the dashed line at
t=0). (B) Box plots of blood flow changes (DBF) after L-NNA
administration within animals of each strain (N=7 each); L-NNA
decreased tumor rBF within C3H (p=0.016), but not within nude
animals (p=0.16). As with previous experiments, nude animals
displayed substantial heterogeneity in DBF.
doi:10.1371/journal.pone.0037322.g005
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multiple times and the longer that a vessel is the more likely it is
that this will happen. Thus, the increased length of small diameter
blood vessels in the tumors of C3H animals could contribute to
our finding that C3H mice bore tumors with smaller-sized vessels.
Solesvik et al. did not consistently detect decreases in vessel
diameter in C3H versus nude mice across all tumor models
studied, but some did indeed show trends toward decreased
diameter in the C3H animals (and the RIF model was not among
those investigated).
Potential factors contributing to differentials in vessel size
between nudes and C3H may be found in studies of the effects of
immunogenicity on tumor-associated fibrosis and interstitial fluid
pressure. Nude animals lack the lymphocyte-laden fibrosis
associated with tumors in immune competent mice [35]. Given
the stronger fibrotic reaction in immune competent animals,
which could increase cell density surrounding the blood vessels, it
comes as no surprise that others report tumor interstitial fluid
pressure to be higher in immune competent mice than in the same
tumor model when grown in nude animals [36]. Our findings of
smaller-sized vessels in the C3H versus nude animals would
therefore be in agreement with expected differentials in tumor
interstitial fluid pressure as a function of immunogenicity. Namely,
vessel compression could result from high interstitial fluid pressure
in immune competent animals, while lower interstitial fluid
pressures in the tumors of immune deficient animals could be
permissive of larger-sized vessels. Taken together these data point
to vascular structure as a variable to be considered in studies of
tumor response to vasomodulation within different murine strains.
Differences in vessel size between the tumors of C3H and nudes
could contribute to the strain-dependent differences in vasore-
sponse due to the effect of vessel size on blood flow. Resistance to
blood flow is inversely related to the fourth power of vessel
diameter [7], predicting that vasoconstriction of a small vessel
would increase flow resistance to a greater magnitude than the
same vasoconstrictive insult in larger vessels (Poiseuille’s law
assuming vessel radius decreases by the same amount in each
case). Under the assumptions that the concentration of blood
vessels is the same in the two models (data show that the vascular
area is the same) and that blood pressure is the same (or changes in
the same way) between the models, one can then calculate that
vasoconstriction of the smaller tumor blood vessels in C3H mice
would lead to larger relative changes in blood flow than would the
same amount of vasoconstriction in the larger vessels of nude mice.
Indeed, PDT-created decreases in tumor rBF were significantly
larger in C3H animals. Moreover, the vasoconstrictor L-NNA
significantly decreased tumor blood flow in C3H animals, while
resulting in smaller, more variable and overall insignificant
decreases in tumor rBF in the nudes.
Our findings of oscillations in tumor blood flow under baseline
conditions are consistent with many previous reports of fluctuating
blood flow or oxygen levels in tumors [2,4,6,37,38,39]. Such
fluctuations have even been noted in studies of PDT along with the
observation, as we made, that they are destroyed by the treatment
[20]. Factors such as tumor size or vessel maturity (expression of
smooth muscle actin, SMA) [9,40] can affect the nature of the
fluctuations, but these characteristics did not differ between the
tumors of C3H versus nudes in our study: mean (SD) tumor size
was 270 (88) mm
3 vs. 292 (61) mm
3 and SMA expression was 0.77
(0.36)% vs. 0.56 (0.58)% in C3H vs. nudes, respectively. The
underlying cause of cyclic blood flow or hypoxia has been
attributed to several factors, including vasomotion linked to
upstream circulation, the local hemodynamics of blood flow
through tortuous tumor vasculature and vascular intussusception
from rapid vessel remodeling [3,41,42]. Our studies do not rule
out contributions from the latter two factors, but the fact that flow
cycled over the tumor as a whole (i.e. the area over which DCS
measured) suggests a less-localized cause for the fluctuations.
Vasomotion could provide one explanation. Using window
chamber models, others have documented vasomotion to occur
when the diameter of tumor-feeding arterioles produced co-
ordinated changes in vessel diameter and blood flow through
downstream daughter vessels [43]. Looking more generally, we
have shown in the present study that the low frequency
fluctuations in tumor blood flow are highly correlated with animal
heart rate.
The median period length of cyclic tumor blood flow in this
study was ,9 and 14 min in nude and C3H mice, respectively,
which is in good agreement with period lengths detected in
fluctuating blood flow or oxygenation in tumors of other
investigations [3,43], including those in humans [44]. Given our
findings that these fluctuations correlate with changes in animal
heart rate, it is interesting to note that this period is similar
between tumors and/or strains as reported herein by us and in the
observations of others [45] because it supports the contribution of
a more general-acting effector, such as heart rate, to fluctuation in
tumor oxygenation or blood flow. Importantly, spontaneous
Figure 6. Tumor vascular structure is also strain-dependent. (A) Vascular area (as a percent of the tumor) and (B) median vessel size in the
tumors of animals of each strain. Vessels were stained by immunochemistry for CD31 in sections collected from each of 4 and 5 tumors from C3H and
nude mice, respectively; p=0.02 for the difference in vessel size between the models. Error bars indicate standard deviations.
doi:10.1371/journal.pone.0037322.g006
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observed [46].
Strain-dependent differences in baseline hemodynamic function
were evident in both cyclic fluctuations and longer-term trends. At
the level of blood flow cycling, tumors of C3H had much more
regular periods, evidenced by significantly higher autocorrelation
functions than those found in the nudes. The C3H also were more
likely to exhibit periodic fluctuations in tumor rBF and these
fluctuations were completely absent from some of the nudes. In
terms of longer term (over 1 hour) trends in tumor rBF, the C3H,
but not the nudes, exhibited increasing blood flow over an hour of
monitoring. Accompanying increases in heart rate were also
detected in these animals. We suggest that these increases are
related to the known vasodilative effect of isoflurane. Whereas we
showed tumor rBF (C3H mice) to increase by ,25% in this study,
Schumacher et al. reported isoflurane to induce a 26% increase in
the diameter of microvessels of rat skeletal muscle [47]. Neither
tumor nor core animal temperature increased over this same
monitoring period; moreover they did not differ between the
strains, which shows that in the context of our investigations strain-
dependent differences in tumor temperature did not exist or
contribute to the differential in long term blood flow trends
between the models.
Due to the anesthesia-induced increase in blood flow in the
C3H animals, phosphorescence lifetime imaging was used to
compare the oxygenation of tumors in C3H versus nude animals.
Average (SD) tumor pO2 after 60 minutes of monitoring, i.e. the
time point at which PDT would begin, was 20 (12) Torr in C3H
and 33 (10) Torr in the nudes, showing substantial overlap
between the strains. Thus, the stronger vascular effects of PDT in
C3H mice could not be attributed to an improved state of
oxygenation relative to the tumors in nude mice. A difference in
Photofrin uptake between RIF tumors of nude and C3H animals
was also ruled out as a cause of strain-dependent differences in
PDT response.
In summary, comparative studies of the same tumor line grown
in C3H and nude mice has found blood flow in the C3H animals
to be more responsive to vascular stress, whether it be locally
(PDT) or systemically (L-NNA) induced. Specifically, PDT
uncouples cyclic fluctuations in tumor blood flow from animal
heart rate, leading to decreases in tumor blood flow that are
significantly greater in the C3H versus nude animals. These results
may in part be explained by the smaller blood vessels of tumors in
C3H mice, which could contribute to the general tighter control of
blood flow in these tumors. All told, these results provide evidence
that the underlying structure and hemodynamics of tumor blood
vessels may inform upon the nature of their response to
a subsequent vascular challenge. Differences in baseline tumor
hemodynamics between animal strains should be considered when
planning and interpreting studies of PDT, or other vaso-
modulating applications.
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